Taken together, our data suggested that DSI protected renal fibrosis against ferroptosis may be partially via SIRT1/GPX4 activation, highlighting that the potential effects of DSI as a novel therapeutic drug for limiting renal fibrosis. This evidence concerns the gene GPX4 and renal fibrosis.